期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

糖基化终产物形成抑制剂研究的进展 被引量：18

Progress on the research of inhibitors of advanced glycation end products formation
下载PDF
导出
摘要 介绍几种治疗糖尿病慢性并发症的糖基化终产物形成抑制剂 ,简述了它们的作用机制。 The inhibitors of advanced glycation end products(AGEs) for treatment of diabetic complications were introduced, their mechanisms of action, prospects of application and future development were reviewed.
作者 李才 侯芳玉 刘忠英
机构地区 吉林大学生物工程研究所 白求恩医科大学基础医学院
出处 《中国新药杂志》 CAS CSCD 北大核心 2001年第2期85-88,共4页 Chinese Journal of New Drugs
关键词 糖基化终产物 糖基化终产物形成抑制剂 糖基化终产物断裂剂 糖尿病 并发症 advanced glycation end products inhibitors of advanced glycation end products breakers of advanced glycation end products diabetic complications
分类号 R977.14 [医药卫生—药品] R587.105 [医药卫生—内分泌]
  • 相关文献

参考文献19

  • 1[1]Vlassara H,Bucala R,Striker L.Pathogenic effects of advanced glycosylatio n:Biochemical,biologic,and clinical implication for diabetes and aging[J].L ab Invest,1994,70(2)∶138-151.
  • 2[2]Vlassara H,Bucala R.Recent progress in advanced glycation and diabe tic vascular disease:role of advanced glycation end product receptors[J].Di abetes,1996,45 (Suppl 3)∶S65-S66.
  • 3[3]Makita Z,Vlassara H,Rayfield E,et al.Hemoglobin AGE:a circulati ng marker of advanced glycosylation[J].Science,1992,258(5082)∶651-653.
  • 4[4]Edelstein D,Brownlee M. Mechanistic studies of advanced glyco sylation end product inhibition by aminoguanidine[J].Diabetes,1992,41(1) ∶26-29.
  • 5[5]Hirsch J, Petrakova E, Feather MS. The reaction of some dic arbonyl sugars with aminoguanidine[J].Carbohydr Res,1992,232(2)∶125-130.
  • 6[6]Tanaka Y,Uchino H,Shimizu T,et al.Effect of metformin o n advanced glycation endproduct formation and peripheral nerve function in strep tozotocin-induced diabetic rats[J].Eur J Pharmacol,1999,376(1)∶17-22.
  • 7[7]Kochakian M,Manjula BN,Egan JJ.Chronic dosing with aminoguanidine a nd novel advanced glycosylation end product-formation inhibitors ameliorates cr oss-linking of tail tendon collagen in STZ-induced diabetic rats[J].Diabe tes,1996,45(12)∶1694-1700.
  • 8[8]Nakamura S,Makita Z,Ishikawa S,et al.Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195,a novel inhibitor of adv anced glycation[J].Diabetes,1997,46(5)∶895-899.
  • 9[9]Miyata T,Ishikawa S,Asahi K,et al.2-isopropylidenehydrazo- no-4-oxo-thiazolidin-5-ylacetanilide (OPB-9195) treatment inhibits t he dev elopment of intimal thickening after baloon injury of rat carotid artery: role o f glycoxidation and lipoxidation reactions in vascular tissue damage[J].FEB S Lett,1999,445(1)∶202-206．
  • 10[10]Tsuchida K,Makita Z,Yamagishi S,et al.Suppression of transforming gr owth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195[J].D iabetologia,1999,42(5)∶579-588.

同被引文献213

引证文献18

二级引证文献166

中国新药杂志
2001年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部